These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24041364)

  • 1. Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force.
    Vemer P; van Voom GA; Ramos IC; Krabbe PF; Al MJ; Feenstra TL
    Value Health; 2013; 16(6):1106-7. PubMed ID: 24041364
    [No Abstract]   [Full Text] [Related]  

  • 2. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.
    Caro JJ; Briggs AH; Siebert U; Kuntz KM;
    Value Health; 2012; 15(6):796-803. PubMed ID: 22999128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The view of a model user on the ISPOR-SMDM modeling good research task force report.
    Berger ML
    Value Health; 2012; 15(6):794-5. PubMed ID: 22999127
    [No Abstract]   [Full Text] [Related]  

  • 4. ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos.
    Caro JJ; Eddy DM; Hollingworth W; Tsevat J; McDonald KM; Wong JB; Briggs AH; Siebert U; Kuntz KM
    Value Health; 2013; 16(6):1108. PubMed ID: 24041365
    [No Abstract]   [Full Text] [Related]  

  • 5. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.
    Karnon J; Stahl J; Brennan A; Caro JJ; Mar J; Möller J;
    Value Health; 2012; 15(6):821-7. PubMed ID: 22999131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.
    Pitman R; Fisman D; Zaric GS; Postma M; Kretzschmar M; Edmunds J; Brisson M;
    Value Health; 2012; 15(6):828-34. PubMed ID: 22999132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.
    Siebert U; Alagoz O; Bayoumi AM; Jahn B; Owens DK; Cohen DJ; Kuntz KM;
    Value Health; 2012; 15(6):812-20. PubMed ID: 22999130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.
    Caro JJ; Briggs AH; Siebert U; Kuntz KM;
    Med Decis Making; 2012; 32(5):667-77. PubMed ID: 22990082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.
    Eddy DM; Hollingworth W; Caro JJ; Tsevat J; McDonald KM; Wong JB;
    Value Health; 2012; 15(6):843-50. PubMed ID: 22999134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.
    Roberts M; Russell LB; Paltiel AD; Chambers M; McEwan P; Krahn M;
    Value Health; 2012; 15(6):804-11. PubMed ID: 22999129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6.
    Briggs AH; Weinstein MC; Fenwick EA; Karnon J; Sculpher MJ; Paltiel AD;
    Value Health; 2012; 15(6):835-42. PubMed ID: 22999133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4.
    Karnon J; Stahl J; Brennan A; Caro JJ; Mar J; Möller J
    Med Decis Making; 2012; 32(5):701-11. PubMed ID: 22990085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.
    Malone DC; Ramsey SD; Patrick DL; Johnson FR; Mullins CD; Roberts MS; Willke RJ; Marshall DA
    Value Health; 2020 Apr; 23(4):409-415. PubMed ID: 32327155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3.
    Siebert U; Alagoz O; Bayoumi AM; Jahn B; Owens DK; Cohen DJ; Kuntz KM
    Med Decis Making; 2012; 32(5):690-700. PubMed ID: 22990084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting Quality of Discrete Event Simulations in Healthcare-Results From a Generic Reporting Checklist.
    Zhang X; Lhachimi SK; Rogowski WH
    Value Health; 2020 Apr; 23(4):506-514. PubMed ID: 32327168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.
    Pitman R; Fisman D; Zaric GS; Postma M; Kretzschmar M; Edmunds J; Brisson M;
    Med Decis Making; 2012; 32(5):712-21. PubMed ID: 22990086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selecting a dynamic simulation modeling method for health care delivery research-part 2: report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force.
    Marshall DA; Burgos-Liz L; IJzerman MJ; Crown W; Padula WV; Wong PK; Pasupathy KS; Higashi MK; Osgood ND;
    Value Health; 2015 Mar; 18(2):147-60. PubMed ID: 25773550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Editorial: Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.
    ISPOR Estimating Health-State Utility for Economic Models in Clinical Studies Task Force
    Value Health; 2016; 19(6):702-703. PubMed ID: 27712694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.